Arkema is engaged in the global chemical industry which is a processing industry based on the transformation in one or several stages of raw materials (oil derivatives, gas, minerals, natural products) into more or less complex chemical products, or into plastics obtained by polymerization. In addition, Co. manufactures a wide range of products for other major industries: construction, packaging, chemicals, automotive, electronics, food manufacturing, pharmaceuticals, etc. Co. operates in this industrial context with a business portfolio focused on three segments: High Performance Materials, Industrial Specialties, and Coating Solutions.
  • TickerAKE
  • ISINFR0010313833
  • ExchangeEuronext Paris
  • SectorChemicals
  • CountryFrance

Analysts

An increasingly favourable environment allows ARKEMA to improve to Neutral

The independent financial analyst theScreener just upgraded the general evaluation of ARKEMA (FR), a company active in the Commodity Chemicals industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains as risky. theScreener believes, however, that a more enabling environment allows the title to increase its general evaluation to Neutral. As of the analysis date September 13, 2019, the closing price was EUR 88.48 and its expected value was estimated at EUR 79.94.

Arkema - June 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Arkema - March 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Arkema: Acquisition of ArrMaz is credit positive

Arkema's acquisition of ArrMaz good strategic fit as it adds exposure to surfactants and is gross leverage neutral

Arkema - December 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Arkema: Update to discussion of key credit factors following change of outlook to positive

Deleveraging and higher share of specialty chemicals make Arkema more resilient and support change of outlook to positive

Emmanuel Matot

Arkema : $ 570m deal struck in specialty sector

>Acquisition of US company ArrMaz - Arkema announced this morning it reached an agreement to buy US company ArrMaz, which generates $ 290m sales (3% of the group's sales) in specialty surfactants for crop nutrition (additives for fertiliser production), mining (additives for ore recovery) and road infrastructure (road additives). The company employs 400 people (nine production sites) and generates 53% of its revenues in North America (vs. 9% in Europe and 38% in the r...

Emmanuel Matot

Arkema : Acquisition pour 570 M$ dans les spécialités

>Acquisition de la société américaine ArrMaz - Arkema annonce ce matin l’acquisition de la société américaine ArrMaz qui réalise 290 M$ de CA (soit 3% du CA du groupe) dans les tensioactifs de spécialités pour la nutrition des cultures (additifs pour la production de fertilisants), les mines (additifs pour la récupération du minerai) et les infrastructures routières (additifs pour les routes). La société emploie 400 personnes (9 sites de production) et réalise 53% de ...

Emmanuel Matot

ODDO : Q1 postviews: profit warning from Solvay, Arkema sticking to its course

>No major surprises in Q1 for Arkema and 2019 guidance reiterated by the management - Arkema’s Q1 2019 results highlighted EBITDA close to forecasts at € 370m (ODDO BHF/consensus = € 370/365m), down 3% on a reported basis and down -7% based on equivalent accounting standards. This negative shift in the trend (reminder: EBITDA 2018 = +6%) is due to weak demand (volumes = -2.5% / slowdown in automotive, oil & gas and electronics + high base of comparison in molecular si...

Emmanuel Matot

ODDO : Postviews T1 : profit warning de Solvay et cap maintenu pour Arkema

>Pas de surprise majeure au T1 pour Arkema et guidance 2019 réitérée par les dirigeants - Les résultats T1 2019 d’Arkema ont mis en avant un EBITDA proche des attentes à 370 M€ (ODDO BHF/consensus = 370/365 M€), en recul de 3% en donnée publiée et de -7% à norme comptable équivalente. Cette inversion négative de tendance (rappel EBITDA 2018 = +6%) s’explique par une faiblesse de la demande (volumes = -2.5% - ralentissement dans l’automobile, le pétrole/gaz et l’électr...

Rob Hales

Morningstar | Arkema Reports Decent 1Q Results; Shares Fairly Valued

No-moat Arkema reported first-quarter EBITDA of EUR 370 million, down 3% over 2018 but broadly in line with consensus. The 3% drop in EBITDA is tracking below full-year guidance for EBITDA to remain flat, but the company expects an improved second half. We are somewhat more conservative, forecasting a 6% decline in 2019 EBITDA given our pessimistic outlook for fluorogases. We don’t expect to make a material change to our forecast or EUR 88 fair value estimate. At current levels, the shares look fairly valued. Coatings solutions was the only segment contributing positive EBITDA growth with a 1...

1 director sold

A director at Arkema sold 4,470 shares at 91.090EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board members ...

Alexandre Iatrides ...
  • Benoit Valleaux
  • Charles Lepetitpas
  • Emmanuel Matot
  • Fehmi Ben Naamane
  • Florent Laroche-Joubert
  • Jean Sassus
  • Jerôme Bodin
  • Johanna Jourdain
  • Khaled Ben Amor
  • Louis Boujard
  • Matthias Desmarais
  • Nicolas David
  • Philippe Ourpatian
  • Pierre Tegner
  • Rémi Adam
  • Roland Pfaender
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/16/2019

...

Alexandre Iatrides ...
  • Benoit Valleaux
  • Charles Lepetitpas
  • Emmanuel Matot
  • Fehmi Ben Naamane
  • Florent Laroche-Joubert
  • Jean Sassus
  • Jerôme Bodin
  • Johanna Jourdain
  • Khaled Ben Amor
  • Louis Boujard
  • Matthias Desmarais
  • Nicolas David
  • Philippe Ourpatian
  • Pierre Tegner
  • Rémi Adam
  • Roland Pfaender
  • Stephane Houri
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 16/05/2019

...

Alain William ...
  • Alexandre Iatrides
  • Alfred Glaser
  • Benoit Valleaux
  • Delphine Brault
  • Emmanuel Matot
  • Florent Laroche-Joubert
  • Jean Sassus
  • Jerôme Bodin
  • Johanna Jourdain
  • Laurence Hofmann
  • Matthias Desmarais
  • Michael Foundoukidis
  • Olfa Taamallah
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/10/2019

...

Alexandre Iatrides ...
  • Anis Zgaya
  • Charles Lepetitpas
  • Christophe Chaput
  • Emmanuel Matot
  • Hela Zarrouk
  • Jeremy Garnier
  • Jerôme Bodin
  • Khaled Ben Amor
  • Nicolas David

ODDO BHF Small & MIDCAP MORNING NEWS - 05/10/2019 Date Performance since listing Date Performance since listing

...

Alain William ...
  • Alexandre Iatrides
  • Alfred Glaser
  • Benoit Valleaux
  • Delphine Brault
  • Emmanuel Matot
  • Florent Laroche-Joubert
  • Jean Sassus
  • Jerôme Bodin
  • Johanna Jourdain
  • Laurence Hofmann
  • Matthias Desmarais
  • Michael Foundoukidis
  • Olfa Taamallah
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau
  • Yan Derocles

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 10/05/2019

...

An increasingly favourable environment allows ARKEMA to improve to Neutral

The independent financial analyst theScreener just upgraded the general evaluation of ARKEMA (FR), a company active in the Commodity Chemicals industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains as risky. theScreener believes, however, that a more enabling environment allows the title to increase its general evaluation to Neutral. As of the analysis date September 13, 2019, the closing price was EUR 88.48 and its expected value was estimated at EUR 79.94.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Carole Braudeau

Accor : Credit Feedback – Oddo BHF Forum 10 and 11 January

Our annual Forum in Lyon brought together 263 companies, including 41% of foreign companies, nearly 545 investors (33% foreigners), almost 6,500 one-to-one meetings. - This document gathers a brief feedback from the bond issuers and CB underlying companies in attendance. - - - - >Investment Grade - Accorhotels, Aéroports de Paris, Arkema, Buzzi Unicem, Carmila, Coface, Easyjet, Edenred, Fresenius Medical Care, Grand City Properties, Icade, JCDecaux, Klépierre, Lanxess, MT...

Carole Braudeau

Accor : Feedback Crédit Forum des 10 et 11 janvier 2019

Notre Forum annuel Oddo BHF 2019 vient de se dérouler à Lyon : il a réuni 263 sociétés, dont 41% étrangères, près de 545 investisseurs (33% étrangers), soit près de 6 500 one-to-one. - Ce document synthétise nos feed-back concernant les émetteurs obligataires présents et sous-jacents d’obligations convertibles. - - - >Investment Grade - Accorhotels, Aéroports de Paris, Arkema, Buzzi Unicem, Carmila, Coface, Easyjet, Edenred, Fresenius Medical Care, Grand City Properties,...

MarketLine Department

Ashland Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Ashland Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Ashland Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlight...

MarketLine Department

Lanxess AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Lanxess AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Lanxess AG since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights T...

MarketLine Department

Nordson Corporation - Strategy, SWOT and Corporate Finance Report

Nordson Corporation - Strategy, SWOT and Corporate Finance Report Summary Nordson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Nordson Corporation (Nordson) is a manufacturer and supplier of differentiated products and systems used to dispense, apply and control adhesives, sealants, polymers, coatings, biomaterials, and other fluids. Its products...

Charles Pinel

Arkema - Assemblée générale des actionnaires du 21 mai 2019

François Enaud, administrateur référent non indépendant car en fonction depuis 13 ans, va quitter le conseil à l'issue de cette assemblée générale et sera remplacé à ce poste par un membre indépendant, Hélène Moreau-Leroy. Par ailleurs, autre point positif, le conseil est composé d'une majorité de membres libres de conflits d'intérêts potentiels. Dans ces conditions, les nominations et renouvellements proposés seront tous soutenus (résolutions 5 à 8). De nouveau, l'attention des actionnaires est attirée sur les niveaux de rémunération du Président-Directeur général qui paraissent excessives à...

Expert Corporate Governance Service (ECGS)

Arkema - AGM and EGM 21 May 2019

François Enaud, Lead Director, who is not considered as independent since he has been in office for 13 years, will leave the Board at the end of this general meeting and will be replaced by an independent member, Hélène Moreau-Leroy. Another positive point, the Board is composed by a majority of independent members. Accordingly, ECGS recommends to APPROVE all four re-elections (resolutions 5 to 8).  Once again, shareholders' attention is drawn to the excessive compensation levels of the Chairman and Chief Executive Officer, which amount to € 4.6 million in 2018. A similar amount could be allo...

Arkema – Proxinvest Corporate Governance Rating ® : D

Proxinvest Corporate Governance Rating ® helps investors integrate governance into their investment decision and identify governance risks and opportunities within their portfolio. Proxinvest Corporate Governance Rating ® Service rates European issuers through the analysis of four main themes : Ownership & Shareholder rights, Board & Committees, Audit & Process, Remuneration. Each theme is rated taking into account several comprehensive sub-categories. Our unique two-step process to achieve each rating includes a first step quantitative valuation and a second step qualitative filter...

Jehanne Leroy

Proxy Report - 18/05/2018

The remuneration awarded to Thierry Le Hénaff, Chairman & CEO, was excessive in 2017. He received € 4.5 M and may receive the same amount next year. Moreover the long term years of this directors, François Enaud and Thierry Morin, reduce the independent rate of the board of directors.

Jehanne Leroy

Proxy Report - 18/05/2018

Cette année, Proxinvest attire de nouveau l'attention des actionnaires sur la rémunération attribuée et la rémunération attribuable à M. Le Hénaff qui paraissent excessive. Ainsi en 2017, le Président Directeur Général a perçu un peu plus de 4,5 M d'euros; et pourrait se voir attribuer pas moins de la même somme en 2018. Ces rémunérations excessives sont étonnantes, surtout pour une entreprise étant membre du SBF 120. Le conseil comprendra avec un nouvel administrateur. Cependant deux administrateurs seront requalifiés à raison de leurs anciennetés dans la société. De ce fait, le taux d'indép...

Jérôme VINERIER

Short term view - ARKEMA : Falling prices.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €87.81. The background trend would be questioned should prices rise above €99.54.

Jérôme VINERIER

Analyse court terme - ARKEMA : Les prix baissent.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 87,81 €. La tendance de fond serait remise en cause en cas de franchissement de 99,54 €.

Jérôme VINERIER

Short term view - ARKEMA : The background trend is clearly bearish.

The background trend is clearly bearish. The movement goes on. The next target is at €87.81, then €84.28. Passing €99.54 would question the continuation of the fall.

Jérôme VINERIER

Analyse court terme - ARKEMA : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Le mouvement se poursuit. Le prochain objectif est à 87,81 €, puis 84,28 €. Le franchissement de 99,54 € remettrait en cause la suite de la baisse.

Jérôme VINERIER

Analyse moyen terme - ARKEMA : La tendance est incertaine.

La tendance est incertaine. Les cours baissent, et il y a une possibilité d'accélération baissière. Une nouvelle tendance baissière tente de démarrer.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch